• Presented By

    Michael Freedman, MD, FAAMA

  • REGISTER

1-Hour Live Webcast

Wednesday, July 24, 2024
8:00 pm ET, 7:00 pm CT, 5:00 pm PT

Overview

Description

This presentation will discuss the use of interosseous membrane stimulation and the proposed mechanism of action of the treatment. Three of the myriad conditions with pain in the distal extremeties for which this stimulation is an effective treatment will also be presented. Participants will learn a safe, minimally invasive and effective acupuncture option.

Learning objectives

At the conclusion of this LIVE webcast physician participants will be able to:

  • Identify at least 3 factors that contribute to the control of blood flow to the extremeties.
  • Describe evidence for autonomically mediate mechanism of action of interosseous membrane stimulation.
  • Identify at least 3 disease processes for which the treatment is effective.

Michael Freedman, MD, FAAMA

Dr. Michael Freedman is a graduate of Baylor College of Medicine in 1981 where he also completed a Neurology residency program in 1986. He served as a United States Navy Reserve Medical Officer from 2003-2018; during most of those years he was attached to the 4th Marine Division. Dr. Freedman completed the HMI course in 2015 and is a Diplomat of the American Board of Medical Acupuncture and a Fellow of the American Academy of Medical Acupuncture. Currently he is employed by the VA at the Greenville NC VA Health Care Center.

To Register

The fee to participate in this LIVE activity is $40/members and $70/non-members ($10 for students) per webcast.

Use the button below to register/pay for the LIVE presentation.

Once paid, access instructions will be emailed to participant. At the conclusion of the LIVE activity, an evaluation/survey must be completed with attestation of credit/participation. Certificate of completion will be emailed when completed evaluation/survey is completed.

Accreditation/Designation

The American Academy of Medical Acupuncture is accredited by the Accreditation Council for Continuing Medical Education (ACCME). The AAMA designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

Michael Freedman, MD, FAAMA has indicated no real or apparent conflicts.

The reviewers and activity planners have no financial relationships to disclose.

Disclosure Policy

AAMA must ensure that anyone who is in a position to control the content of the education activity has disclosed all financial relationships that you have had in the past 24 months (even if now ended) with ineligible companies. We define ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.